NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception to June 30, 2022, were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We may generate
non-operating
income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a Business Combination.
For the three months ended June 30, 2022, we had a net income of $326,059, which consisted of interest earned on marketable securities held in the trust account of $639,164, offset by formation and operating expenses of $207,300 and a loss on the value of the FPA asset of $105,805.
For the three months ended June 30, 2021, we had net income of $270,269, which consisted of a gain on the value of the FPA of $507,612 and interest earned on marketable securities held in the trust account of $6,839, offset by formation and operating expenses of $244,182.
For the six months ended June 30, 2022, we had a net loss of $406,931, which consisted of formation and operating expenses of $716,497 and a loss on the value of the FPA asset of $366,326, offset by interest earned on marketable securities held in the trust account of $675,892.
For the six months ended June 30, 2021, we had net loss of $1,644,255 which consisted of a loss on the value of the FPA of $1,156,478 and formation and operating expenses of $500,478, offset by $12,701 of interest earned on marketable securities held in the trust account.
Liquidity, Capital Resources and Going Concern
Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of Class B ordinary shares by our Sponsor and advances from our Sponsor.
On January 11, 2021, we consummated our Initial Public Offering of 45,000,000 shares, which included the full exercise by the underwriters of the
over-allotment
option to purchase an additional 5,000,000 shares, at $10.00 per share, generating gross proceeds of $450,000,000 (the “Initial Public Offering”). Simultaneously with the closing of the Initial Public Offering, we consummated the sale of an aggregate of 1,100,000 Private Placement Shares to our sponsor at a price of $10.00 per share, generating gross proceeds of $11,000,000.
Following the Initial Public Offering, the full exercise of the over-allotment option, and the sale of the Private Placement Shares, a total of $450,000,000 was placed in the Trust Account, and we had $1,995,000 of cash held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes. We incurred $25,304,775 in transaction costs, including $9,000,000 of underwriting fees, $15,750,000 of deferred underwriting fees and $554,775 of other offering costs.
For the six months ended June 30, 2022, net cash used in operating activities was $453,347. The net loss of $406,931 was offset by the interest earned on marketable securities held in trust of $675,892 and changes in value of the FPA asset of $366,326 and in operating assets and liabilities used $263,150 of cash from operating activities.
For the six months ended June 30, 2021, net cash used in operating activities was $911,360. The net loss of $1,644,255 was offset by the interest earned on marketable securities held in trust of $12,701 and changes in value of the FPA asset of $1,156,478 and changes in operating assets and liabilities used $410,882 of cash from operating activities.
At June 30, 2022 and December 31, 2021, we had cash held in the Trust Account of $450,704,039 and 450,028,147, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable (if applicable) and deferred underwriting commissions) and the proceeds from the sale of the forward purchase shares to complete our Business Combination. To the extent that our shares or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the post-Business Combination entity, make other acquisitions and pursue our growth strategies.
At June 30, 2022 and December 31, 2021, we had cash of $8,334 and $398,681, held outside of the Trust Account, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, properties or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $2,000,000 of such loans may be convertible into shares of the post-Business Combination entity at a price of $10.00 per share at the option of the lender.